|
EXP002301
|
Novel peptide (RATH) mediated delivery of peptide nucleic acids for antiviral i…
|
2021 |
RATH-1
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002302
|
Novel peptide (RATH) mediated delivery of peptide nucleic acids for antiviral i…
|
2021 |
RATH-2
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002303
|
Neoantigen-specific mRNA/DC vaccines for effective anticancer immunotherapy
|
2024 |
RALA
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002304
|
Neoantigen-specific mRNA/DC vaccines for effective anticancer immunotherapy
|
2024 |
RALA
|
mRNA
|
no |
|
|
yes |
yes |
|
EXP002305
|
Neoantigen-specific mRNA/DC vaccines for effective anticancer immunotherapy
|
2024 |
RALA
|
mRNA
|
no |
|
|
yes |
no |
|
EXP002306
|
Intraocular siRNA Delivery Mediated by Penetratin Derivative to Silence Orthoto…
|
2023 |
89WP (penetratin derivative)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002307
|
Intraocular siRNA Delivery Mediated by Penetratin Derivative to Silence Orthoto…
|
2023 |
89WP (penetratin derivative)
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002308
|
Comparison of Physicochemical Properties of LipoParticles as mRNA Carrier Prepa…
|
2022 |
LAH4-L1
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP002309
|
Comparison of Physicochemical Properties of LipoParticles as mRNA Carrier Prepa…
|
2022 |
LAH4-L1
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP002310
|
Higher Order Architecture of Designer Peptides Forms Bioinspired 10 nm siRNA De…
|
2019 |
V1
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002311
|
Higher Order Architecture of Designer Peptides Forms Bioinspired 10 nm siRNA De…
|
2019 |
V2
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002312
|
Higher Order Architecture of Designer Peptides Forms Bioinspired 10 nm siRNA De…
|
2019 |
V1N
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002313
|
Higher Order Architecture of Designer Peptides Forms Bioinspired 10 nm siRNA De…
|
2019 |
V2N
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002314
|
Local Silencing of Connective Tissue Growth Factor by siRNA/Peptide Improves De…
|
2018 |
KALA
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002315
|
Local Silencing of Connective Tissue Growth Factor by siRNA/Peptide Improves De…
|
2018 |
MPG-DNLS
|
siRNA
|
no |
no |
|
no |
no |
|
EXP002316
|
Local Silencing of Connective Tissue Growth Factor by siRNA/Peptide Improves De…
|
2018 |
KALA
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP002317
|
Local Silencing of Connective Tissue Growth Factor by siRNA/Peptide Improves De…
|
2018 |
MPG-DNLS
|
siRNA
|
no |
|
|
yes |
no |
|
EXP002318
|
Target-specific delivery of siRNA into hepatoma cells’ cytoplasm by bifunctiona…
|
2017 |
LHRH-MPGΔNLS
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002319
|
Enhancing WRAP-Based Nanoparticles for Small Interfering Ribonucleic Acid Deliv…
|
2025 |
WRAP5
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002320
|
Enhancing WRAP-Based Nanoparticles for Small Interfering Ribonucleic Acid Deliv…
|
2025 |
AcHy-W5
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002321
|
Enhancing WRAP-Based Nanoparticles for Small Interfering Ribonucleic Acid Deliv…
|
2025 |
AcHyOMe-W5
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002322
|
Enhancing WRAP-Based Nanoparticles for Small Interfering Ribonucleic Acid Deliv…
|
2025 |
P-Hy-W5
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002323
|
Enhancing WRAP-Based Nanoparticles for Small Interfering Ribonucleic Acid Deliv…
|
2025 |
P-HyOMe-W5
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002324
|
Novel Efficient Cell-Penetrating Peptide–Mediated Strategy for Enhancing Telome…
|
2015 |
PepFect15 (PF15)
|
ASO
|
yes |
yes |
yes |
no |
no |
|
EXP002325
|
Novel Efficient Cell-Penetrating Peptide–Mediated Strategy for Enhancing Telome…
|
2015 |
PepFect15 (PF15)
|
ASO
|
yes |
no |
yes |
no |
no |
|
EXP002326
|
Self-assembled redox-responsive BRD4 siRNA nanoparticles: formulation and its i…
|
2025 |
LMWP
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002327
|
Studies on the Effect of Lipofectamine and Cell-Penetrating Peptide on the Prop…
|
2023 |
Tat
|
oligonucleotide
|
no |
no |
|
no |
no |
|
EXP002328
|
Endosomolytic peptides enable the cellular delivery of peptide nucleic acids
|
2024 |
R10
|
SCO
|
yes |
no |
no |
no |
no |
|
EXP002329
|
Endosomolytic peptides enable the cellular delivery of peptide nucleic acids
|
2024 |
azide-R10
|
SCO
|
yes |
no |
no |
no |
no |
|
EXP002330
|
Endosomolytic peptides enable the cellular delivery of peptide nucleic acids
|
2024 |
L17E
|
SCO
|
yes |
yes |
yes |
no |
no |
|
EXP002331
|
Endosomolytic peptides enable the cellular delivery of peptide nucleic acids
|
2024 |
azide-L17E
|
SCO
|
yes |
yes |
yes |
no |
no |
|
EXP002332
|
Endosomolytic peptides enable the cellular delivery of peptide nucleic acids
|
2024 |
L17E-azide
|
SCO
|
yes |
yes |
yes |
no |
no |
|
EXP002333
|
Endosomolytic peptides enable the cellular delivery of peptide nucleic acids
|
2024 |
L17ER4
|
SCO
|
yes |
yes |
yes |
no |
no |
|
EXP002334
|
Endosomolytic peptides enable the cellular delivery of peptide nucleic acids
|
2024 |
azide-L17ER4
|
SCO
|
yes |
yes |
yes |
no |
no |
|
EXP002335
|
Endosomolytic peptides enable the cellular delivery of peptide nucleic acids
|
2024 |
L17ER4-azide
|
SCO
|
yes |
yes |
yes |
no |
no |
|
EXP002336
|
Therapeutic uses of peptide nucleic acids (PNA) in oncology
|
2003 |
pAntennapedia
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002337
|
Therapeutic uses of peptide nucleic acids (PNA) in oncology
|
2003 |
HIV Tat
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002338
|
Enhancing RNAi efficiency in Phytophthora infestans using cell-penetrating pept…
|
2026 |
FAM-Arg9
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002339
|
Enhancing RNAi efficiency in Phytophthora infestans using cell-penetrating pept…
|
2026 |
FAM-MAP
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002340
|
Enhancing RNAi efficiency in Phytophthora infestans using cell-penetrating pept…
|
2026 |
FAM-TAT
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002341
|
Enhancing RNAi efficiency in Phytophthora infestans using cell-penetrating pept…
|
2026 |
FAM-Tp10
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002342
|
Cyclization and thermal modulation of a β-hairpin peptide for efficient cellula…
|
2026 |
Ac-SVS1
|
siRNA
|
yes |
no |
no |
no |
no |
|
EXP002343
|
Cyclization and thermal modulation of a β-hairpin peptide for efficient cellula…
|
2026 |
Cyc-SVS1
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002344
|
Cyclization and thermal modulation of a β-hairpin peptide for efficient cellula…
|
2026 |
Cyc-SVS1
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002345
|
Redox-cleavable disulfide linker enhances siRNA delivery by prodrug-type bifunc…
|
2025 |
PI
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002346
|
Redox-cleavable disulfide linker enhances siRNA delivery by prodrug-type bifunc…
|
2025 |
PI-cRGD
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002347
|
Redox-cleavable disulfide linker enhances siRNA delivery by prodrug-type bifunc…
|
2025 |
PI-linker-cRGD
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002348
|
Multiprotein Silencing Using WRAP-Based Nanoparticles: A Proof of Concept
|
2025 |
WRAP5
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002349
|
Multiprotein Silencing Using WRAP-Based Nanoparticles: A Proof of Concept
|
2025 |
WRAP5
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002350
|
Multiprotein Silencing Using WRAP-Based Nanoparticles: A Proof of Concept
|
2025 |
WRAP5
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002351
|
Multiprotein Silencing Using WRAP-Based Nanoparticles: A Proof of Concept
|
2025 |
WRAP5
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002352
|
Multiprotein Silencing Using WRAP-Based Nanoparticles: A Proof of Concept
|
2025 |
WRAP5
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002353
|
Multiprotein Silencing Using WRAP-Based Nanoparticles: A Proof of Concept
|
2025 |
WRAP5
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002354
|
Suppression of tumor invasion and migration in breast cancer cells following de…
|
2012 |
PR39
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002355
|
Suppression of tumor invasion and migration in breast cancer cells following de…
|
2012 |
FITC-PR39
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002356
|
Microenvironment-tailored micelles restrain carcinoma–astrocyte crosstalk for b…
|
2022 |
CSKC
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002357
|
Microenvironment-tailored micelles restrain carcinoma–astrocyte crosstalk for b…
|
2022 |
CSKC
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002358
|
PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in so…
|
2011 |
PF14
|
SCO
|
yes |
yes |
yes |
no |
no |
|
EXP002359
|
PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in so…
|
2011 |
PF14
|
SCO
|
yes |
yes |
yes |
no |
no |
|
EXP002360
|
PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in so…
|
2011 |
PF14A
|
SCO
|
yes |
no |
no |
no |
no |
|
EXP002361
|
PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in so…
|
2011 |
PF14A
|
SCO
|
yes |
no |
no |
no |
no |
|
EXP002362
|
Delivery of siRNA and other macromolecules into skin and cells using a peptide …
|
2011 |
SPACE
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002363
|
Delivery of siRNA and other macromolecules into skin and cells using a peptide …
|
2011 |
SPACE
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002364
|
Delivery of siRNA and other macromolecules into skin and cells using a peptide …
|
2011 |
SPACE
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002365
|
Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian ca…
|
2012 |
TP–LyP-1
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002366
|
Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian ca…
|
2012 |
TP–LyP-1
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002367
|
Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian ca…
|
2012 |
Transportan
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002368
|
Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian ca…
|
2012 |
PolyR9
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002369
|
Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian ca…
|
2012 |
TAT
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002370
|
Local gene silencing in plants via synthetic dsRNA and carrier peptide
|
2014 |
(KH)9-Bp100
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002371
|
Local gene silencing in plants via synthetic dsRNA and carrier peptide
|
2014 |
(KH)9-Bp100
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002372
|
Brain tumor-targeted therapy by systemic delivery of siRNA with transferrin rec…
|
2016 |
T7
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002373
|
Brain tumor-targeted therapy by systemic delivery of siRNA with transferrin rec…
|
2016 |
T7
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002374
|
Lipid envelope-type nanoparticle incorporating a multifunctional peptide for sy…
|
2013 |
GALA
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002375
|
Lipid envelope-type nanoparticle incorporating a multifunctional peptide for sy…
|
2013 |
GALA
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002376
|
Development of an antisense RNA delivery system using conjugates of the MS2 bac…
|
2009 |
HIV-1 Tat(47–57)
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002377
|
Delivery of siRNA therapeutics using cowpea chlorotic mottle virus-like particl…
|
2019 |
L17E
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002378
|
Delivery of siRNA therapeutics using cowpea chlorotic mottle virus-like particl…
|
2019 |
L17E
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002379
|
Cell-Penetrating Magnetic Nanoparticles for Highly Efficient Delivery and Intra…
|
2012 |
Protamine
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002380
|
Visualizing the dynamics of viral replication in living cells via Tat peptide d…
|
2008 |
Tat(47-57)
|
ASO
|
yes |
no |
|
no |
no |
|
EXP002381
|
Hyaluronidase-triggered anticancer drug and siRNA delivery from cascaded target…
|
2017 |
PEGA-pVEC
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002382
|
Hyaluronidase-triggered anticancer drug and siRNA delivery from cascaded target…
|
2017 |
PEGA-pVEC
|
siRNA
|
no |
|
yes |
yes |
yes |
|
EXP002383
|
A Multifunctional Lipid-Based Nanodevice for the Highly Specific Codelivery of …
|
2019 |
STR-R8
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002384
|
A Multifunctional Lipid-Based Nanodevice for the Highly Specific Codelivery of …
|
2019 |
SP94
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002385
|
Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model b…
|
2019 |
Tat
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002386
|
Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model b…
|
2019 |
Tat
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002387
|
Selective Cell Penetrating Peptide-Functionalized Envelope-Type Chimeric Lipope…
|
2019 |
CPP33
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002388
|
Selective Cell Penetrating Peptide-Functionalized Envelope-Type Chimeric Lipope…
|
2019 |
CPP33
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002389
|
Gene Silencing Mediated by siRNA-binding Fusion Proteins Is Attenuated by Doubl…
|
2012 |
PTD-DRBD
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002390
|
Gene Silencing Mediated by siRNA-binding Fusion Proteins Is Attenuated by Doubl…
|
2012 |
PTD-2×DRBD
|
siRNA
|
yes |
no |
no |
no |
no |
|
EXP002391
|
Gene Silencing Mediated by siRNA-binding Fusion Proteins Is Attenuated by Doubl…
|
2012 |
B2-2×DRBD
|
siRNA
|
yes |
no |
no |
no |
no |
|
EXP002392
|
Cellular uptake mechanism and comparative in vitro cytotoxicity studies of mono…
|
2018 |
LMWP
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002393
|
Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy
|
2018 |
HIV TAT-Cys
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002394
|
Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy
|
2018 |
HIV TAT-Cys
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002395
|
Photosensitizing Carrier Proteins for Photoinducible RNA Interference
|
2011 |
HIV TAT
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002396
|
Small Interfering RNA-Mediated Control of Virus Replication in the CNS Is Thera…
|
2018 |
RVG9R
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002397
|
Small Interfering RNA-Mediated Control of Virus Replication in the CNS Is Thera…
|
2018 |
RVG9R
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002398
|
A solid-phase method for peptide–siRNA covalent conjugates based on click chemi…
|
2012 |
LALLAK
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002399
|
Synergistically enhanced anticancer effect of codelivered curcumin and siPlk1 b…
|
2019 |
RGD
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002400
|
Synergistically enhanced anticancer effect of codelivered curcumin and siPlk1 b…
|
2019 |
RGD
|
siRNA
|
yes |
|
|
yes |
yes |